Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

A Feasibility Study Evaluating Von Willebrand Factor in Patients with Gastrointestinal Angiodysplasia

Nicholas L.J. Chornenki, Julie Grabell, Mackenzie L Bowman, David Good, Lawrence Hookey, Paula James

Blood (2023) 142 (Supplement 1): 1250.

https://doi.org/10.1182/blood-2023-174301

Published: 2023

Journal Articles

Diagnosing Absolute Iron-Deficiency Anemia in Patients on Hemodialysis in a Tertiary Care Centre: A Retrospective Chart Review

Robert C. Clayden, MSc, MD, Wilma Hopman, MSc, Frances Macleod, RN, David Good, MD FRCPC, Jocelyn Garland, MD FRCPC, Lawrence Hookey, MD FRCPC, Annette E. Hay

Blood (2019) 134 (Supplement_1): 4814.

https://doi.org/10.1182/blood-2019-129197

Published: 2019

Journal Articles

Validation and Clinical Impact of the Oncomine Myeloid Targeted DNA and RNA Ion Semiconductor Sequencing Assay

Christina Ferrone, BScH, Henry Wong, PhD, Laura Semenuk, Brooke Snetsinger, MSc, Xiao Zhang, David Good, MD FRCPC, Graeme Quest, MSc, MD FRCPC, Harriet Feilotter, PhD FCCMG, FACMG, Michael J. Rauh, MD PhD

Blood (2018) 132 (Supplement 1): 5523.

https://doi.org/10.1182/blood-2018-99-116576

Published: 2018

Journal Articles

Differential Expression of TCF3 Target Genes Defines Subclasses of Diffuse Large B-Cell Lymphoma with Striking Differences in Clinical Outcome Following R-CHOP Therapy

Kathrin Tyryshkin, PhD, Yi D Li, MD, David Good, MD, Lois E. Shepherd, MD, Tara Baetz, MD FRCPC, Michael J. Rauh, MD PhD, David P. LeBrun, MD

Blood (2016) 128 (22): 3037.

https://doi.org/10.1182/blood.V128.22.3037.3037

Published: 2016

Journal Articles

Microenvironmental Links Between TET2/DNMT3A Mutations and Arginase 1 Overexpression in Human MDS/CMML

Alyssa Cull, MSc, Brooke Snetsinger, MSc, David Good, MD, Rena Buckstein, MD, Richard A. Wells, MD DPhil, Michael J. Rauh, MD PhD

Blood (2016) 128 (22): 3164.

https://doi.org/10.1182/blood.V128.22.3164.3164

Published: 2016

Journal Articles

Rituximab Improves Overall Survival In Patients Treated With CODOX-M/IVAC For Burkitt Lymphoma (BL) and B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and BL: A Single Center Experience and Review Of The Literature

Anca Prica, MD, Ariella Pratzer, Matthew C Cheung, MD, Kim Thompson, Eugenia Piliotis, MD, Neil L Berinstein, MD, Kevin R. Imrie, MD, Rahim Pradhan, Anju Vyas, David Good, MD, Liying Zhang, PhD, Rena Buckstein, MD

Blood (2013) 122 (21): 5093.

https://doi.org/10.1182/blood.V122.21.5093.5093

Published: 2013

Journal Articles

Increased Arginase 1 Expression In Human MDS, CMML and Murine Models Points To Dysregulation Of Common Immunosuppressive Signaling Networks

Alyssa Cull, MSc, Brooke Snetsinger, MSc, Iqra Mumal, BSc, Flora Shan, BSc, David Good, MD, FRCPC, Michael J. Rauh, MD, PhD

Blood (2013) 122 (21): 1578.

https://doi.org/10.1182/blood.V122.21.1578.1578

Published: 2013

Journal Articles

A 7-Gene Microrna Signature Characteristic of Mantle Cell Lymphoma Reveals Focal Adhesion and Integrin Signalling, Proteasome-Mediated Degradation, and the PI3K Signalling Cascade As Important to MCL Pathogenesis

Blood (2012) 120 (21): 1586.

https://doi.org/10.1182/blood.V120.21.1586.1586

Published: 2012

Journal Articles

Comparing MicroRNA Expression In Aggressive and Indolent Non-Hodgkin Lymphomas Identifies a Prognostic Signature for Mantle Cell Lymphoma

Rashmi S. Goswami, BSc, MD, FRCPC, Levi Waldron, Ph.D., Patricia P Reis, Ph.D., Yali Xuan, Wei Xu, Ph.D., John Kuruvilla, David Good, MD, Denis Bailey, MD, Alanna Church, MD, Tara Baetz, MD, David LeBrun, MD, Raymond Lai, MD, Ph.D., Laurie Sehn, MD, MPH, Pedro Farinha, MD, Randy D. Gascoyne, MD, Michael Crump, MD, FRCPC, Igor Jurisica, Ph.D., Suzanne Kamel-Reid, Ph.D.

Blood (2010) 116 (21): 800.

https://doi.org/10.1182/blood.V116.21.800.800

Published: 2010

Journal Articles

The Addition of Rituximab and/or Alpha-Interferon to High Dose Chemotherapy and Autologous Stem Cell Transplantation for Patients with Relapsed Follicular Lymphoma Produces Durable Progression Free Survival and Molecular Remissions

Sita Bhella, MD, Neil L Berinstein, MD, FRCPC, Nancy Pennell, BSc, Matthew Cheung, MD, FRCPC, Kevin R. Imrie, MD, FRCPC, Violet Miliken, Marciano D. Reis, MD, FRCPC, Alden Chesney, MD, FRCPC, David Good, MD, FRCPC, Lisa Hicks, MD, MSc, FRCPC, Eugenia Piliotis, MD, FRCPC, Michael Crump, MD, FRCPC, Rena Buckstein, MD, FRCPC

Blood (2010) 116 (21): 1357.

https://doi.org/10.1182/blood.V116.21.1357.1357

Published: 2010

Journal Articles

Arginase and YKL-40, Effectors of Immunosuppressive Myeloid Cells, Are Over-Expressed In the Bone Marrow of Most Chronic Myelomonocytic Leukemia Patients, and Are Potential Prognostic Biomarkers In Myelodysplastic Syndrome

Michael J. Rauh, MD, PhD, Deeksha Mahendru, BSc, Roman Shapiro, BSc, Alden Chesney, MD, David Good, MD, Marciano D. Reis, MD, Adam Lam, Gerald Krystal, PhD, Rena Buckstein, MD, FRCPC, Richard A. Wells, MD, DPhil

Blood (2010) 116 (21): 1855.

https://doi.org/10.1182/blood.V116.21.1855.1855

Published: 2010

Journal Articles

The Effects of Azacitidine on Quality of Life Measured Longitudinally In MDS Patients Treated at a Tertiary Care Center

Sarah A. Ingber, MD, Kim Thompson, Adam Lam, Alex Mamedov, Liying Zhang, PhD, Alibhai Shabbir, MD, David Good, MD, Alden Chesney, MD, Marciano D. Reis, MD, Matthew Cheung, MD, Vicky Harris, RN, Richard A. Wells, MD, DPhil, Rena Buckstein, MD

Blood (2010) 116 (21): 2571.

https://doi.org/10.1182/blood.V116.21.2571.2571

Published: 2010

NARROW

A Feasibility Study Evaluating Von Willebrand Factor in Patients with Gastrointestinal Angiodysplasia

Diagnosing Absolute Iron-Deficiency Anemia in Patients on Hemodialysis in a Tertiary Care Centre: A Retrospective Chart Review

Validation and Clinical Impact of the Oncomine Myeloid Targeted DNA and RNA Ion Semiconductor Sequencing Assay

Differential Expression of TCF3 Target Genes Defines Subclasses of Diffuse Large B-Cell Lymphoma with Striking Differences in Clinical Outcome Following R-CHOP Therapy

Microenvironmental Links Between TET2/DNMT3A Mutations and Arginase 1 Overexpression in Human MDS/CMML

Rituximab Improves Overall Survival In Patients Treated With CODOX-M/IVAC For Burkitt Lymphoma (BL) and B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and BL: A Single Center Experience and Review Of The Literature

Increased Arginase 1 Expression In Human MDS, CMML and Murine Models Points To Dysregulation Of Common Immunosuppressive Signaling Networks

A 7-Gene Microrna Signature Characteristic of Mantle Cell Lymphoma Reveals Focal Adhesion and Integrin Signalling, Proteasome-Mediated Degradation, and the PI3K Signalling Cascade As Important to MCL Pathogenesis

Comparing MicroRNA Expression In Aggressive and Indolent Non-Hodgkin Lymphomas Identifies a Prognostic Signature for Mantle Cell Lymphoma

The Addition of Rituximab and/or Alpha-Interferon to High Dose Chemotherapy and Autologous Stem Cell Transplantation for Patients with Relapsed Follicular Lymphoma Produces Durable Progression Free Survival and Molecular Remissions

Arginase and YKL-40, Effectors of Immunosuppressive Myeloid Cells, Are Over-Expressed In the Bone Marrow of Most Chronic Myelomonocytic Leukemia Patients, and Are Potential Prognostic Biomarkers In Myelodysplastic Syndrome

The Effects of Azacitidine on Quality of Life Measured Longitudinally In MDS Patients Treated at a Tertiary Care Center

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only